Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Expanded Access (Compassionate Use) If you have a life-threatening obesity-related condition, have exhausted all approved treatments, and cannot enroll in a clinical trial, your doctor can request expanded access directly from Eli Lilly
Remaining food was measured at 2, 4, 6, 8, and 24 hours post-dose
Effectiveness and Side Effects: Tirzepatide is a dual receptor agonist, which is why it is a potentially more potent treatment, but its use may also be associated with more side effects compared to liraglutide
Cohort 1 contained 101 individuals with negative Covid-19 test results, whilst cohort 2 contained 122 individuals with positive results displaying mild symptoms or who were asymptomatic
18.5 cm mean reduction in waist circumference
US$ 25.72
US$ 29.41
US$ 28.11
